RecruitingNot ApplicableNCT06687161

Treating Insomnia in Mild Cognitive Impairment

Neuromodulation and Cognitive Behavioral Therapy for Insomnia in MCI

Sponsor

Beth Israel Deaconess Medical Center

Enrollment

30 participants

Start Date

May 1, 2025

Study Type

INTERVENTIONAL

Conditions

Insomnia Mild Cognitive Impairment (MCI)

Summary

The goal of this study is to test a new way to improve sleep quality in persons living with mild cognitive impairment. The treatment combines a safe and gentle way to stimulate the brain, called transcranial magnetic stimulation, with a psychological treatment, called cognitive behavioral therapy for insomnia.

Eligibility

Min Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Cognitive behavioral therapy for insomnia (CBT-I) and a medical device called Transcranial Magnetic Stimulation (TMS) therapy for people with insomnia and mild cognitive impairment (mci). The study is currently recruiting participants at 1 location. People eligible for this study include aged 60 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscranial Magnetic Stimulation (TMS) therapy

Each treatment consists of 600 TMS pulses (\~3 minutes) applied to the L-DLPFC

BEHAVIORALCognitive behavioral therapy for insomnia (CBT-I)

9-week fully-automated, Internet-delivered CBT-I program: SHUTi OASIS (Sleep Healthy Using the Internet for Older Adult Sufferers of Insomnia and Sleeplessness)